0% found this document useful (0 votes)
29 views17 pages

DM 2021-0114 Guidelines On The MGMT and Admin of The Initial 600,000 Donated SARS-CoV-2 Vaccine (Vero Cell) Inactivated Coronavac (Sinovac) Doses

This document contains several annexes providing information for COVID-19 vaccination in the Philippines. Annex A contains a fact sheet for vaccination providers, Annex B outlines the vaccination card, and Annex C is an informed consent form. Annex D establishes the order of priority for receiving vaccines, with COVID referral hospitals first and closed institutions last. Annex E includes a health assessment form and Annex F contains the emergency use authorization issued for the Sinovac vaccine.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
29 views17 pages

DM 2021-0114 Guidelines On The MGMT and Admin of The Initial 600,000 Donated SARS-CoV-2 Vaccine (Vero Cell) Inactivated Coronavac (Sinovac) Doses

This document contains several annexes providing information for COVID-19 vaccination in the Philippines. Annex A contains a fact sheet for vaccination providers, Annex B outlines the vaccination card, and Annex C is an informed consent form. Annex D establishes the order of priority for receiving vaccines, with COVID referral hospitals first and closed institutions last. Annex E includes a health assessment form and Annex F contains the emergency use authorization issued for the Sinovac vaccine.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 17

ANNEX A.

Philippine FDA Fact Sheet for vaccination providers

7
ANNEX B. Vaccination Card
Access the document here: bit.ly/RESBAKUNAMaterials

8
ANNEX C. INFORMED CONSENT FORM
Access the document here: bit.ly/RESBAKUNAMaterials

9
ANNEX D. ORDER OF PRIORITY FOR PRIORITY GROUP A1
For priority group A1, all workers in a health facility shall be taken as a group and provided
vaccines in the following order of precedence:
1. COVID-19 referral hospitals designated by the DOH;
2. Public and private hospitals and infirmaries providing COVID-19 care, as prioritized
based on service capability, starting from level 3 hospitals, to level 2 hospitals to level
1 hospitals, and then infirmaries;
3. Among hospitals with a common service capability, the order of priority shall be from
facilities owned by the DOH, then facilities owned by LGUs, and then facilities
owned by private entities;
4. Isolation and quarantine facilities such as temporary treatment and monitoring
facilities and converted facilities (e.g. hotels, schools, etc) that cater to COVID-19
suspect, probable, and confirmed cases, close contacts, and travellers in quarantine;
5. Remaining hospitals including facilities of uniformed services not catering to
COVID-19 cases;
6. Government owned primary care based facilities such as Urban Health Centers, Rural
Health Units and Barangay Health Stations, birthing homes, and Local Health Offices
to include members of BHERTS, contact tracers, social workers;
7. Stand-alone facilities, clinics and diagnostic centers, and other facilities otherwise not
specified (e.g. clinics, dialysis centers, dental clinics, and COVID-19 laboratories),
dealing with COVID-19 cases, contacts, and specimens for research purposes,
screening and case management coordinated through their respective local
government units; and
8. Closed institutions and settings such as, but not limited to, nursing homes,
orphanages, jails, detention centers, correctional facilities, drug treatment and
rehabilitation centers, and Bureau of Corrections.

10
ANNEX E. HEALTH ASSESSMENT FORM

Access the document here: bit.ly/RESBAKUNAMaterials

11
12
ANNEX F. EMERGENCY USE AUTHORIZATION FOR SINOVAC
(https://www.fda.gov.ph/wp-content/uploads/2021/03/EUA-SINOVAC-WEBSITE-3.pdf)

13
14
15
16
17

You might also like